Explaining Fatty Liver Scan Results

Clinical Scenario

Pete Thompson, 51, calls worried about his scan results. He had persistently raised ALT (55 and 60 on two occasions 3 months apart) and an ultrasound was arranged. The ultrasound shows fatty liver with no focal lesions, no biliary dilatation, and a normal-appearing pancreas. Pete has gained approximately 15kg in the past year, drinks 25-30 units of alcohol weekly, and is terrified that the scan shows cancer. He has no other significant medical history.

What This Case Tests

Addressing cancer anxiety before explaining the diagnosis; explaining non-alcoholic fatty liver disease (NAFLD) or alcohol-related fatty liver in accessible language; using the diagnosis as a motivational lever for lifestyle change; assessing alcohol intake honestly; stratifying liver disease severity using the FIB-4 or NAFLD fibrosis score.

Common Mistakes Trainees Make

The three most common mistakes are: not addressing the cancer fear immediately (Pete is terrified — if you explain fatty liver without first saying it is not cancer, he will not hear anything you say), missing the alcohol contribution (25-30 units per week is above recommended limits and fatty liver in this context may be alcohol-related, not just NAFLD), and presenting the diagnosis as benign without explaining progression risk (fatty liver can progress to steatohepatitis, fibrosis, and cirrhosis if the cause is not addressed).

The Consultation Challenge

Pete is scared. He has been waiting for scan results and is expecting the worst. Your first words need to address this directly.

Open with the cancer reassurance: "I want to start with the most important thing — the scan does not show any signs of cancer. There are no masses, no tumours, nothing sinister. So let me put that worry to rest straight away." Watch the relief — then you have a receptive patient.

Now explain the finding. Fatty liver means fat has accumulated in the liver cells. Use an analogy: "Think of it like a healthy liver being a lean steak, and yours has become more like a marbled one. The fat is building up inside the liver cells, and over time that can cause the liver to become inflamed."

Assess the cause honestly. Pete has two contributing factors: weight gain (15kg in a year) and alcohol (25-30 units weekly). Both independently cause fatty liver, and together the effect is compounded. You need to address both, but the alcohol conversation requires sensitivity — many patients underreport and become defensive.

Ask about alcohol without judgment: "I need to ask about your drinking — not to lecture you, but because it directly affects your liver. Can you walk me through a typical week?" If he is drinking 25-30 units, this exceeds the recommended 14 units per week and is likely contributing significantly to the fatty liver. This may be alcohol-related fatty liver disease (ARFLD) rather than NAFLD, or a combination.

Explain the progression risk. Fatty liver is not benign — it can progress through steatohepatitis (inflammation) to fibrosis and eventually cirrhosis. However, at the fatty liver stage, it is entirely reversible with lifestyle change. This is both a warning and a motivator: "Right now, your liver can recover completely. But if we do not make changes, the damage can become permanent."

Stratify the risk. Calculate the FIB-4 score using age, ALT, AST, and platelet count (if available from the bloods) to assess fibrosis risk. If low risk, manage in primary care with lifestyle intervention. If intermediate or high risk, refer to hepatology.

Set concrete lifestyle targets: reduce alcohol to under 14 units weekly (or abstain if possible), aim for 5-10% body weight loss (7.5-15kg at his current weight), increase physical activity (150 minutes moderate per week), and dietary modification (reduce saturated fat and sugar). Repeat LFTs in 3-6 months.

Time check: Spend the first 2 minutes addressing the cancer fear. Explain fatty liver between minutes 3-5. Assess alcohol and weight between minutes 6-8. Explain progression risk and lifestyle targets between minutes 9-11. Use the final minute for investigations, follow-up, and motivation.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you review the scan findings systematically, assess both alcohol and metabolic causes of fatty liver, take an honest alcohol history (quantified in units), screen for metabolic syndrome features (BMI, waist circumference, blood pressure, glucose, lipids), and calculate or plan a FIB-4 score for fibrosis risk stratification. A trainee who diagnoses NAFLD without adequately assessing alcohol intake will miss a critical dimension.

Clinical Management and Medical Complexity: Examiners expect explanation of the progression pathway (fat to inflammation to fibrosis to cirrhosis), knowledge of reversibility at the fatty liver stage, concrete lifestyle targets (specific alcohol reduction, percentage weight loss goal, exercise recommendation), a plan for repeat LFTs, and knowledge of when to refer to hepatology (intermediate or high FIB-4 score). Demonstrating fibrosis risk stratification shows clinical depth.

Relating to Others: Examiners assess whether you address the cancer fear immediately and effectively, explain fatty liver in accessible language, discuss alcohol without judgment, and use the diagnosis as motivation rather than doom. Pete should leave relieved that it is not cancer, clear about what fatty liver means, and motivated to make changes.

Example Opening

Strong opening: "Hello Pete, I know you have been worried about your scan results, so let me start with the most important thing — the scan does not show cancer. No masses, no tumours, nothing like that. So that is the first piece of good news."

When explaining fatty liver: "What the scan does show is something called fatty liver. Basically, fat has built up inside your liver cells. About 1 in 4 people have this, and the good news is that at this stage it is completely reversible — your liver can go back to normal. But to do that, we need to talk about a couple of things."

When discussing alcohol: "I need to ask about your drinking — this is not about judging you, it is about understanding what is happening with your liver. Can you talk me through a typical week?"

Avoid: "Your scan shows fatty liver — this can lead to cirrhosis and liver failure." (Leads with the worst-case scenario before addressing the cancer fear or explaining the condition).

How This Appears in the SCA

Explaining scan results to an anxious patient is a core SCA skill. This case combines result communication, cancer anxiety management, alcohol assessment, and motivational interviewing for lifestyle change. Examiners assess whether you address the fear first, explain the condition clearly, and use the diagnosis as a lever for change.

Key Statistic

Non-alcoholic fatty liver disease affects approximately 25-30% of adults in the UK, making it the most common liver condition. Approximately 20% of people with fatty liver progress to steatohepatitis, and of those, 10-20% develop fibrosis or cirrhosis. The condition is completely reversible at the fatty liver stage with lifestyle modification.

Relevant Guidelines

• NICE NG49: Non-alcoholic fatty liver disease — assessment and management
• NICE CG100: Alcohol-use disorders — diagnosis and management
• British Liver Trust guidance on fatty liver.

Frequently Asked Questions

Should I address the cancer fear before explaining the diagnosis?

Always. A patient who is terrified of cancer cannot absorb information about fatty liver until that fear is addressed. Lead with the reassurance: "The scan does not show cancer." Then pause — let the relief land before continuing. This principle applies to all result-giving consultations where cancer anxiety is present. Examiners specifically assess whether you manage the emotional context before delivering the clinical information.

How do I differentiate NAFLD from alcohol-related fatty liver disease?

The distinction depends on alcohol intake. NAFLD is diagnosed when fatty liver is present with alcohol consumption below 20g/day for women or 30g/day for men. Above these thresholds, the diagnosis shifts to alcohol-related fatty liver disease (ARFLD). In practice, many patients have both metabolic and alcohol contributions. Pete drinks 25-30 units weekly (approximately 200-240g alcohol per week) — this exceeds the NAFLD threshold and suggests significant alcohol contribution.

What is the FIB-4 score and why should I calculate it?

FIB-4 is a simple fibrosis risk score calculated from age, AST, ALT, and platelet count. It stratifies patients into low risk (manage in primary care), intermediate risk (further assessment with enhanced liver fibrosis test or Fibroscan), and high risk (refer to hepatology). NICE NG49 recommends using FIB-4 for all patients with NAFLD. Demonstrating awareness of fibrosis stratification shows that you are managing beyond the initial diagnosis.

What lifestyle targets should I set for fatty liver reversal?

Weight loss of 5-10% of body weight is the most effective single intervention — this has been shown to reverse steatosis and improve liver inflammation. Alcohol reduction to under 14 units per week (or abstinence if alcohol-related). Regular exercise of 150 minutes moderate intensity per week. Dietary modification: reduce saturated fat, refined sugar, and processed carbohydrates. These targets should be specific, measurable, and achievable — vague advice to "eat better" is ineffective.

When should I refer fatty liver to hepatology?

Refer if: the FIB-4 score is intermediate or high (suggesting possible fibrosis), the enhanced liver fibrosis (ELF) test is elevated, there are signs of advanced liver disease (spider naevi, ascites, jaundice, splenomegaly), liver enzymes continue to rise despite lifestyle modification, or the patient has co-existing chronic liver disease (hepatitis B/C, autoimmune hepatitis). For straightforward fatty liver with a low FIB-4 score, primary care management with lifestyle intervention is appropriate.